康宁(GLW)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

GLW 康宁

交易中 05-02 10:52:54 EDT

33.36

-0.12

-0.36%

最高33.80	最低33.08	成交量97.32万
今开33.76	昨收33.48	日振幅2.17%
总市值273.22亿	流通市值246.40亿	总股本8.19亿
成交额3,239万	换手率0.13%	流通股本7.39亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"GLW","market":"US","secType":"STK","nameCN":"康宁","latestPrice":33.36,"timestamp":1714661568387,"preClose":33.48,"halted":0,"volume":973172,"delay":0,"floatShares":738606550,"shares":819000000,"eps":0.720209,"marketStatus":"交易中","marketStatusCode":2,"change":-0.12,"latestTime":"05-02 10:52:54 EDT","open":33.76,"high":33.8,"low":33.075,"amount":32389375.206784,"amplitude":0.021655,"askPrice":33.37,"askSize":570,"bidPrice":33.36,"bidSize":5,"shortable":3,"etf":0,"ttmEps":0.720209,"exchange":"NYSE","tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1714680000000},"adr":0,"adjPreClose":33.48,"adrRate":0,"dividendRate":0.033573,"preHourTrading":{"tag":"盘前","latestPrice":33.73,"preClose":33.48,"latestTime":"09:27 EDT","volume":315,"amount":10673.972819999999,"timestamp":1714656438713},"postHourTrading":{"tag":"盘后","latestPrice":33.5,"preClose":33.48,"latestTime":"19:46 EDT","volume":153487,"amount":5138770.5476,"timestamp":1714607177860},"volumeRatio":0.638337,"optionData":{"bulkOrders":[{"symbol":"GLW","call":true,"expireDate":1715918400000,"strike":"32.0","timestamp":1714592062534,"price":1.9500000476837158,"volume":2359,"amount":460005,"type":"-"},{"symbol":"GLW","call":false,"expireDate":1723780800000,"strike":"33.0","timestamp":1714574516509,"price":1.2999999523162842,"volume":1900,"amount":247000,"type":"-"}]}},"requestUrl":"/m/hq/s/GLW","defaultTab":"news","newsList":[{"id":"2431263673","title":"康宁盘中异动 急速拉升5.11%报33.41美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2431263673","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2431263673?lang=zh_cn&edition=full","pubTime":"2024-04-30 21:32","pubTimestamp":1714483955,"startTime":"0","endTime":"0","summary":"北京时间2024年04月30日21时32分，康宁股票出现异动，股价急速拉升5.11%。截至发稿，该股报33.41美元/股，成交量18.2566万股，换手率0.02%，振幅0.79%。康宁股票所在的电子元器件行业中，整体跌幅为0.04%。消息层面，截至21时32分，康宁股票正面舆情新闻比例100%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404302132357a57c0d7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404302132357a57c0d7&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2431328857","title":"康宁预计第二季度核心销售额高于预期，因运营商支出稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=2431328857","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2431328857?lang=zh_cn&edition=full","pubTime":"2024-04-30 21:07","pubTimestamp":1714482444,"startTime":"0","endTime":"0","summary":"    路透4月30日 - 特种玻璃生产商康宁  周二预计，第二季度核心销售额将高于华尔街预期，这主要得益于价格上涨和电信客户支出复苏对其光纤电缆的健康需求。根据 LSEG 的数据，康宁预计第二季度核心销售额约为 34 亿美元，而分析师平均预期为 33.3 亿美元。该公司生产的大猩猩玻璃被三星  和苹果  等公司用于智能手机，其第一季度核心销售总额为32.6亿美元，高于预期的31.2亿美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2430758854","title":"康宁医院(02120)将于6月28日派发末期股息每10股3元","url":"https://stock-news.laohu8.com/highlight/detail?id=2430758854","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2430758854?lang=zh_cn&edition=full","pubTime":"2024-04-27 06:26","pubTimestamp":1714170365,"startTime":"0","endTime":"0","summary":"康宁 医院 (02120)发布公告，将于2024年6月28日派发截至2023年12月31日止年度的末期股息每10股3元人民币。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042706402387b53031&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042706402387b53031&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2430272768","title":"康宁公司  预计每股收益35美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2430272768","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2430272768?lang=zh_cn&edition=full","pubTime":"2024-04-26 21:28","pubTimestamp":1714138101,"startTime":"0","endTime":"0","summary":"   * 康宁公司   将于4月30日公布截至2024年3月31日的财报，预计该公司的季度收入将出现下降。* LSEG 分析师对康宁公司的平均预期为每股收益 35 美分。该公司在 2024 年 1 月 30 日发布的截至 3 月 31 日的每股收益指导值介于 0.32 美元和 0.38 美元之间。* 华尔街对康宁公司 12 个月目标价的中位数为 35.00 美元，高于上一交易日 31.35 美元的收盘价。4月26日 - 上一季度业绩。除非另有说明，所有数字均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2426268949","title":"小摩：维持Corning(GLW.US)评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2426268949","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2426268949?lang=zh_cn&edition=full","pubTime":"2024-04-11 21:21","pubTimestamp":1712841660,"startTime":"0","endTime":"0","summary":"小摩：维持Corning(GLW.US)评级，由中性调整至中性评级,目标价由34.00美元调整至36.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240411213723876800f6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240411213723876800f6&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2425048076","title":"南向资金4月3日净卖出康宁杰瑞制药-B0.80万股 连续7日减持","url":"https://stock-news.laohu8.com/highlight/detail?id=2425048076","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2425048076?lang=zh_cn&edition=full","pubTime":"2024-04-08 09:31","pubTimestamp":1712539881,"startTime":"0","endTime":"0","summary":"4月3日，南向资金减持康宁杰瑞制药-B0.80万股连续7日减持。截止当日收盘，港股通共持有康宁杰瑞制药-B25478.09万股，占流通股26.40%。康宁杰瑞制药-B近5个交易日上涨2.88%，港股通累计减持129.90万股；近20个交易日下跌5.10%，港股通累计减持60.80万股。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404080944588afc91c6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404080944588afc91c6&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2423106391","title":"康宁杰瑞公布2023年度全年业绩及近期业务进展","url":"https://stock-news.laohu8.com/highlight/detail?id=2423106391","media":"美通社","top":-1,"share":"https://www.laohu8.com/m/news/2423106391?lang=zh_cn&edition=full","pubTime":"2024-03-29 09:56","pubTimestamp":1711677360,"startTime":"0","endTime":"0","summary":"苏州2024年3月29日 /美通社/ -- 康宁杰瑞生物制药公布了截至2023年12月31日的2023年度全年业绩和近期业务进展。2023年度实现产品收入195.55百万元人民币，同比增长32.54%。2023年度研发开支407.52百万元人民币，同比下降12.97%。财务状况稳健，截至2023年12月31日现金储备为1407.24百万元人民币。目前KN046多项注册临床研究正在进行中。相关结果于2023年10月在ESMO大会上展示。KN026联合多西他赛一线治疗HER2阳性复发或转移性乳腺癌的临床研究取得了良好的耐受性及临床获益。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://wwwold.prnasia.com/story/archive/4374441_ZH74441_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2422686905","title":"康宁杰瑞皮下注射药物JSKN033在澳大利亚完成首例患者给药","url":"https://stock-news.laohu8.com/highlight/detail?id=2422686905","media":"美通社","top":-1,"share":"https://www.laohu8.com/m/news/2422686905?lang=zh_cn&edition=full","pubTime":"2024-03-26 09:57","pubTimestamp":1711418220,"startTime":"0","endTime":"0","summary":"苏州2024年3月26日 /美通社/ -- 康宁杰瑞生物制药宣布，皮下注射HER2双抗ADC与PD-L1复方制剂JSKN033用于治疗HER2表达晚期或转移性实体瘤的临床研究，已经在澳大利亚完成首例患者给药。关于JSKN033 JSKN033是康宁杰瑞自主研发的全球首个皮下注射HER2双特异性抗体偶联药物和免疫检查点抑制剂复方制剂，由JSKN003和恩沃利单抗组成。康宁杰瑞始终聚焦未满足的临床需求，不断开发安全、负担得起、具有全球竞争优势的抗肿瘤药物，惠及患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://wwwold.prnasia.com/story/archive/4370686_ZH70686_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2422554068","title":"泰康保险集团股份有限公司创始人陈东升：中国已进入新寿险的时代","url":"https://stock-news.laohu8.com/highlight/detail?id=2422554068","media":"中国新闻网","top":-1,"share":"https://www.laohu8.com/m/news/2422554068?lang=zh_cn&edition=full","pubTime":"2024-03-25 13:49","pubTimestamp":1711345772,"startTime":"0","endTime":"0","summary":"3月24日下午举行了“大健康产业专题研讨会”，泰康保险集团股份有限公司创始人、董事长兼首席执行官陈东升在“小组讨论二”环节的发言中表示：中国已进入新寿险的时代，即保险服务，就是医养康宁服务再加投资，形成支付、服务、资产三端协同。基于泰康保险在健康养老商业模式上的创新实践，陈东升谈到“长寿经济”。这一商业创新模式正在改变中国老年人的生活方式和对待生命的态度。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403251350158b5fbc92&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403251350158b5fbc92&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2422009793","title":"尹力分别会见苹果公司美敦力公司康宁公司负责人","url":"https://stock-news.laohu8.com/highlight/detail?id=2422009793","media":"北京日报客户端","top":-1,"share":"https://www.laohu8.com/m/news/2422009793?lang=zh_cn&edition=full","pubTime":"2024-03-25 06:00","pubTimestamp":1711317600,"startTime":"0","endTime":"0","summary":"本报讯 昨天下午，市委书记尹力分别会见了美国苹果公司首席执行官蒂姆·库克、爱尔兰美敦力公司董事长兼首席执行官杰夫·马萨和美国康宁公司董事长兼首席执行官魏文德。　　在会见马萨时，尹力说，北京始终把市民群众健康摆在重要位置，致力于不断提升卫生健康事业发展水平。希望美敦力公司积极推动医疗创新中心落地北京，在京建设医疗器械生产基地。　　市领导莫高义、夏林茂、靳伟分别参加会见。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/jjxw/2024-03-25/doc-inapnrxc0228044.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2024-03-25/doc-inapnrxc0228044.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2420982214","title":"南向资金3月15日净买入康宁杰瑞制药-B61.80万股 连续5日增持","url":"https://stock-news.laohu8.com/highlight/detail?id=2420982214","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2420982214?lang=zh_cn&edition=full","pubTime":"2024-03-18 09:31","pubTimestamp":1710725492,"startTime":"0","endTime":"0","summary":"3月15日, 南向资金增持康宁杰瑞制药-B61.80万股，连续5日增持。截止当日收盘，港股通共持有康宁杰瑞制药-B25604.49万股，占流通股26.52%。康宁杰瑞制药-B近5个交易日上涨11.59%，港股通累计增持154.30万股；近20个交易日上涨14.29%，港股通累计增持121.80万股。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403180945548790a3d6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403180945548790a3d6&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2419435639","title":"德龙激光：占公司总股本12.17%的限售股将于11月20日解禁上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2419435639","media":"集微网","top":-1,"share":"https://www.laohu8.com/m/news/2419435639?lang=zh_cn&edition=full","pubTime":"2024-03-15 15:34","pubTimestamp":1710488082,"startTime":"0","endTime":"0","summary":"德龙激光 11月12日发布首次公开发行部分限售股上市流通的公告，本次上市流通的限售股数量为1258万股，占公司总股本的12.17%，限售期为自取得股份之日起36个月。本次限售股上市流通日期为2023年11月20日。根据一份交易所文件，苏州德龙激光11月8日与康宁签署协议，收购该部门康宁激光技术的全部股权，康宁11月9日（周四）证实了这一交易。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403151539358b367fb2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403151539358b367fb2&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2419137596","title":"港股异动 | 永泰生物-B(06978)涨超8% 公司近期携手康宁公司拓展产品商业化合作","url":"https://stock-news.laohu8.com/highlight/detail?id=2419137596","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2419137596?lang=zh_cn&edition=full","pubTime":"2024-03-14 10:35","pubTimestamp":1710383720,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，永泰生物-B(06978)涨超8%，截至发稿，涨8.41%，报3.61港元。消息面上，3月1日，永泰生物与康宁公司在京签订了商务合作备忘录。据悉，随着商务合作备忘录的签署，双方将在定制化产品、测试实验室、新产品的开发和市场推广等方面进行更深层次的合作，以助推永泰重要研发管线的商业化及落地工作。兴业证券此前研报指出，细胞免疫疗法近年快速成长，展现出极大的潜力。公司深耕细胞免疫治疗领域多年，拥有高度整合的T细胞免疫治疗药物研发平台和生产基地，其管线在多个细分领域均有布局，部分产品的研发进度亦国内领先，有望享受行业成长的红利。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1086261.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2419699689","title":"康宁杰瑞将于AACR 2024年会上公布JSKN003治疗HER2表达实体瘤的临床研究数据","url":"https://stock-news.laohu8.com/highlight/detail?id=2419699689","media":"美通社","top":-1,"share":"https://www.laohu8.com/m/news/2419699689?lang=zh_cn&edition=full","pubTime":"2024-03-14 08:39","pubTimestamp":1710376740,"startTime":"0","endTime":"0","summary":"本届AACR年会将于当地时间2024年4月5-10日在美国圣地亚哥举行。本次AACR年会将发布这一研究的更新结果。关于JSKN003 JSKN003为靶向HER2双表位的新型抗体偶联药物，由康宁杰瑞利用特有的糖定点偶联平台自主研发。JSKN003结合肿瘤细胞表面的HER2，通过HER2介导的细胞内吞释放拓扑异构酶Ⅰ抑制剂，进而发挥抗肿瘤作用。目前JSKN003正在澳大利亚和中国开展多项临床研究，针对HER2低表达乳腺癌适应症已在国内进入Ⅲ期临床阶段。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://wwwold.prnasia.com/story/archive/4361174_ZH61174_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2414453352","title":"南向资金2月27日净买入康宁杰瑞制药-B23.30万股 连续3日增持","url":"https://stock-news.laohu8.com/highlight/detail?id=2414453352","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2414453352?lang=zh_cn&edition=full","pubTime":"2024-02-28 09:31","pubTimestamp":1709083882,"startTime":"0","endTime":"0","summary":"2月27日, 南向资金增持康宁杰瑞制药-B23.30万股，连续3日增持。截止当日收盘，港股通共持有康宁杰瑞制药-B25577.59万股，占流通股26.50%。康宁杰瑞制药-B近5个交易日上涨15.27%，港股通累计增持49.60万股；近20个交易日上涨14.00%，港股通累计减持282.50万股。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402280947108ae9335f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402280947108ae9335f&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2409494081","title":"康宁杰瑞KN046联合白蛋白结合型紫杉醇一线治疗晚期三阴乳腺癌研究结果在Nature子刊全文发表","url":"https://stock-news.laohu8.com/highlight/detail?id=2409494081","media":"美通社","top":-1,"share":"https://www.laohu8.com/m/news/2409494081?lang=zh_cn&edition=full","pubTime":"2024-02-06 10:00","pubTimestamp":1707184800,"startTime":"0","endTime":"0","summary":"苏州2024年2月6日 /美通社/ --康宁杰瑞生物制药宣布，PD-L1/CTLA-4双抗KN046联合白蛋白结合型紫杉醇一线治疗晚期三阴乳腺癌的Ⅱ期临床研究结果，近日在国际知名期刊Nature Communications在线发表。研究共入组27例初治局部晚期不可切除或转移性三阴乳腺癌女性患者。结果表明，KN046联合白蛋白结合型紫杉醇一线治疗三阴乳腺癌显示出令人欣喜的无进展生存期和总生存期获益，且耐受性良好，安全性可控。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://wwwold.prnasia.com/story/archive/4329708_ZH29708_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2408901337","title":"光通信行业点评：康宁下游客户24年需求向好 META与AMAZON24年资本开支预计上行","url":"https://stock-news.laohu8.com/highlight/detail?id=2408901337","media":"和讯","top":-1,"share":"https://www.laohu8.com/m/news/2408901337?lang=zh_cn&edition=full","pubTime":"2024-02-04 09:19","pubTimestamp":1707009579,"startTime":"0","endTime":"0","summary":"23Q4 康宁收入下降但毛利率改善，2024 年运营商和超大数据中心需求有望持续好转。根据公司业绩会，康宁预计销售额上行，并且预计40%的收入增长来自于光通信业务，主要受益于前期运营商去库后以及超大数据中心在AI 算力设施上的需求上行。管理层预计2024 年第一季度的核心销售额约为 31 亿美元，并预计第一季度将是全年中的低谷期，随后受到运营商需求恢复业绩将回暖。23Q4 业绩超市场预期，Meta24 年将加大在Metaverse 和AI 领域的资本开支。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240204091941876ba591&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240204091941876ba591&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2408620515","title":"德龙激光(688170.SH)：目前德国康宁激光的财务报告审计工作正在进行中","url":"https://stock-news.laohu8.com/highlight/detail?id=2408620515","media":"格隆汇资讯","top":-1,"share":"https://www.laohu8.com/m/news/2408620515?lang=zh_cn&edition=full","pubTime":"2024-02-02 15:44","pubTimestamp":1706859887,"startTime":"0","endTime":"0","summary":"格隆汇2月2日丨德龙激光(688170.SH)近日在接待机构投资者调研时表示，目前德国康宁激光的财务报告审计工作正在进行中，公司将在审计完成后启动董事会和股东大会审议程序。同时本次交易需要中国、美国及德国相关政府机构审批或备案通过后方能实施，相关审批仍在进行中，尚未取得结果。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240202154454876673c6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240202154454876673c6&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2408861625","title":"南向资金2月1日净卖出康宁杰瑞制药-B21.10万股 连续3日减持","url":"https://stock-news.laohu8.com/highlight/detail?id=2408861625","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2408861625?lang=zh_cn&edition=full","pubTime":"2024-02-02 09:31","pubTimestamp":1706837472,"startTime":"0","endTime":"0","summary":"2月1日，南向资金减持康宁杰瑞制药-B21.10万股连续3日减持。截止当日收盘，港股通共持有康宁杰瑞制药-B25654.89万股，占流通股26.58%。康宁杰瑞制药-B近5个交易日下跌17.74%，港股通累计增持43.70万股；近20个交易日下跌36.25%，港股通累计减持126.60万股。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024020209432087658e9f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024020209432087658e9f&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.corning.com","stockEarnings":[{"period":"1week","weight":0.0622},{"period":"1month","weight":0.0248},{"period":"3month","weight":0.0433},{"period":"6month","weight":0.1987},{"period":"1year","weight":0.0305},{"period":"ytd","weight":0.0995}],"compareEarnings":[{"period":"1week","weight":-0.01},{"period":"1month","weight":-0.0418},{"period":"3month","weight":0.0228},{"period":"6month","weight":0.1511},{"period":"1year","weight":0.2179},{"period":"ytd","weight":0.0527}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"康宁公司成立于1936年12月在纽约州成立，公司名称于1989年4月28日由康宁玻璃厂改为康宁公司。康宁公司是世界领先的专业玻璃和陶瓷制造商。170多年来，康宁将其在玻璃科学、陶瓷科学和光学物理领域无与伦比的专业知识与深厚的制造和工程能力相结合，开发出能够改变行业、提升人们生活的定义类别的产品。康宁的市场包括光通信、移动消费电子产品、显示、汽车、太阳能、半导体和生命科学。康宁的行业领先产品包括用于移动设备的耐损伤盖板玻璃；用于先进显示器的精密玻璃；用于最先进通信网络的光纤和电缆、无线技术和连接解决方案；加速药物发现和交付的可信产品；以及用于汽车和卡车的清洁空气技术。康宁在15个国家的124家工厂生产产品，并在五个可报告的部门开展业务：光通信、显示技术、特种材料、环境技术和生命科学。","yearOnYearQuotes":[{"month":1,"riseRate":0.636364,"avgChangeRate":0.037814},{"month":2,"riseRate":0.568182,"avgChangeRate":-0.000324},{"month":3,"riseRate":0.659091,"avgChangeRate":0.03063},{"month":4,"riseRate":0.511111,"avgChangeRate":0.009335},{"month":5,"riseRate":0.577778,"avgChangeRate":0.011093},{"month":6,"riseRate":0.568182,"avgChangeRate":0.010128},{"month":7,"riseRate":0.431818,"avgChangeRate":-0.014155},{"month":8,"riseRate":0.454545,"avgChangeRate":-0.005745},{"month":9,"riseRate":0.477273,"avgChangeRate":-0.01259},{"month":10,"riseRate":0.5,"avgChangeRate":0.003472},{"month":11,"riseRate":0.704545,"avgChangeRate":0.060649},{"month":12,"riseRate":0.5,"avgChangeRate":0.004405}],"exchange":"NYSE","name":"康宁","nameEN":"Corning"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"康宁(GLW)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供康宁(GLW)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"康宁,GLW,康宁股票,康宁股票老虎,康宁股票老虎国际,康宁行情,康宁股票行情,康宁股价,康宁股市,康宁股票价格,康宁股票交易,康宁股票购买,康宁股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"康宁(GLW)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供康宁(GLW)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}